Nasal Nitric Oxide Sampling In 0-5-year-old Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Controls

M. Kragh (Copenhagen, Denmark), M. Holgersen (Copenhagen, Denmark), J. Marthin (Copenhagen, Denmark), K. Nielsen (Copenhagen, Denmark)

Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kragh (Copenhagen, Denmark), M. Holgersen (Copenhagen, Denmark), J. Marthin (Copenhagen, Denmark), K. Nielsen (Copenhagen, Denmark). Nasal Nitric Oxide Sampling In 0-5-year-old Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Controls. 3158

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020


Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Comparison of Impulse Oscillometry With Spirometry in Patients With Non Cystic Fibrosis Bronchiectasis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Dynamic Balance, Exercise Capacity and Muscle Oxygenation in Children with Non Cystic Fibrosis Bronchiectasis
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020


Gait Parameters and Functional Balance in Adults with Non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia
Year: 2019

Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Increased Osteoporosis and Hospitalization in Non-Cystic Fibrosis Bronchiectasis (NCFBr) Adults with Desaturation during 6 Minute Walk Test: a Five-year Study
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

Histopathologic and Molecular Analysis of Idiopathic Pulmonary Fibrosis Lungs from Patients Treated with Pirfenidone or Nintedanib
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Evaluation of Serum Chitotriozidase Activity and C - reactive protein and Albumin Ratio in Cystic Fibrosis and Bronchopulmonary Dysplasia
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018




Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019